Oncogenic pursuit of CagA is mediated by aberrant activation of multiple signaling cascades that are known to be altered in gastric cancer (RAS/ERK, WNT/β-catenin, JAK/STAT, PI3K/AKT, and others) and inhibition of tumor suppressors. This evidence concerns the gene S100A8 and gastric cancer.